Hypomagnesemia in Type 2 Diabetic Patients

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hypomagnesemia in Type 2 Diabetic Patients trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 2

NCT03567824

MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus

To determine the effect of MLD10 (magnesium L-lactate dihydrate extended-release caplets) 10 mEq BID on serum magnesium in Type 2 diabetic patients with hypomag…

Location not specified200 participantsStarted 2026-03-01

Treatment: Magnesium L-lactate dihydrate, Placebo Oral Tablet